Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
REMASTer: REcurrent Brain Metastases After SRS Trial
- Conditions
- Brain MetastasesRadiation NecrosisRecurrent TumorRecurrent Metastases
- Interventions
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- Monteris Medical
- Target Recruit Count
- 261
- Registration Number
- NCT05124912
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
🇺🇸University of Maryland, Baltimore, Maryland, United States
PatiEnt Neuropsychological outcomeS After laseR Ablation
- Conditions
- Cognitive Change
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Monteris Medical
- Target Recruit Count
- 81
- Registration Number
- NCT05075850
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Advent Health Orlando, Orlando, Florida, United States
🇺🇸University of Kansas Medical Center, Kansas City, Kansas, United States
Feasibility Study on LITT for Newly Diagnosed Glioblastoma
- Conditions
- Glioblastoma
- Interventions
- Device: NeuroBlate SystemDrug: Radiation therapy and temozolomide
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Monteris Medical
- Target Recruit Count
- 3
- Registration Number
- NCT02880410
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States
Feasibility Study on LITT for Medical Refractory Epilepsy
- Conditions
- Epilepsy
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Monteris Medical
- Target Recruit Count
- 4
- Registration Number
- NCT02820740
- Locations
- 🇺🇸
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸University of Kansas Medical Center, Kansas City, Kansas, United States
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
- Conditions
- Primary Brain TumorEpileptic/Seizure FociMetastatic Brain TumorMovement Disorders
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Monteris Medical
- Target Recruit Count
- 1153
- Registration Number
- NCT02392078
- Locations
- 🇺🇸
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸University of California, San Diego, La Jolla, California, United States
- Prev
- 1
- 2
- Next